Anlon Healthcare IPO
ListedMainboardOpens 26 August 2025Closes 29 August 2025
Anlon Healthcare is a chemical manufacturing company engaged in the production of high-purity pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). These products are used as raw materials in…
Anlon Healthcare is a chemical manufacturing company engaged in the production of high-purity pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). These products are used as raw materials in various finished dosages like tablets, capsules, ointments, and syrups, as well as in nutraceuticals, personal care, and veterinary products. The company is one of the few domestic manufacturers of loxoprofen sodium dihydrate, a key ingredient for pain and inflammation treatment. It has 65 commercialized products, with a robust pipeline of 28 products at the pilot stage and 49 products under lab testing. Anlon has a manufacturing facility in Rajkot, Gujarat, which is equipped with an installed capacity of 400 MTPA and four in-house laboratories. The company has received Drug Master File (DMF) approvals from regulatory bodies in Brazil, China, and Japan, which enhances its export potential.
Show moreShow less
Key ratios
As per RHP / filingsTimeline
IPO Opens
26 Aug
IPO Closes
29 Aug
Allotment
1 Sept
Listing
3 Sept
IPO Timeline & Listing Details
| Event | Date |
|---|---|
| IPO Open Date | 26 August 2025 |
| IPO Close Date | 29 August 2025 |
| Allotment Date | 1 September 2025 |
| Listing Date | 3 September 2025 |
Investment Categories
| Category | Lots | Amount |
|---|---|---|
Retail (Min) | 1 | ₹14,924 |
Retail (Max)Just less than ₹2,00,000 | 13 | ₹1,94,012 |
SHNI (Min)Just above ₹2,00,000 | 14 | ₹2,08,936 |
SHNI (Max)Below ₹10,00,000 | 67 | ₹9,99,908 |
BHNIAbove ₹10,00,000 | 68 | ₹10,14,832 |
IPO Objectives
- Funding capital expenditure requirements for Proposed Expansion.
- Full or part repayment and/or prepayment of certain outstanding secured borrowings.
- Funding the working capital requirements of the Company.
- General corporate purposes.
Strengths
- The company has a strong product portfolio with 65 commercialized products and a scalable business model that includes a pipeline of new products under development.
- It benefits from high entry and exit barriers due to long customer approval cycles, which helps create strong customer loyalty and retention.
- The company has strong promoters and an experienced management team with deep industry expertise, providing strategic leadership.
- It has shown consistent financial growth, with revenue up 81% and profit after tax (PAT) rising by 112% between FY24 and FY25, indicating a strong financial turnaround.
- With a low debt-to-equity ratio of 0.73, the company has a much healthier balance sheet compared to previous years.
Weaknesses
- The company's revenue growth has been inconsistent, with a sharp decline in FY24, which raises concerns about business stability and its vulnerability to market disruptions.
- It has high customer concentration, as a small number of clients account for a significant portion of its revenue, making the company vulnerable to losing a major customer.
- The business operates with a single manufacturing facility in Rajkot, which could be a point of vulnerability to any localized disruptions.
- The company is working capital intensive, which is a concern for its cash flow, as a large portion of the IPO proceeds will be used for this purpose.
- It relies on a limited number of suppliers for raw materials, which exposes the company to potential supply chain risks and price volatility.
Financial Performance
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets (₹ Cr.) | 181.3 | 128 | 111.55 |
| Revenue (₹ Cr.) | 120.46 | 66.69 | 113.12 |
| PAT (₹ Cr.) | 20.52 | 9.66 | 5.82 |
| Net Worth (₹ Cr.) | 80.42 | 21.03 | 7.37 |
Peer Comparison
| Company | P/B Ratio | P/E Ratio | RONW (%) | Net Worth (₹ Cr.) |
|---|---|---|---|---|
| Anlon Healthcare | 4.51 | 23.57 | 40.45% | 80.42 |
| Kronox Lab Sciences | 6.92 | 24.37 | 28.26% | 90.11 |
| Acutaas Chemicals | 8.85 | 61.3 | 12.15% | 683 |
Subscription Details
Daily Bids Status
| Category | Day 1 | Day 2 | Day 3 |
|---|---|---|---|
| QIB | 0.91x | 1.01x | 1.07x |
| NII | 0.71x | 2.09x | 10.61x |
| S-HNI | 1.16x | 3.51x | 16.69x |
| B-HNI | 0.48x | 1.38x | 7.56x |
| RII | 8.99x | 22.33x | 47.26x |
| Total | 1.69x | 3.3x | 7.12x |
Overall Subscription Statistics
| Category | Shares Offered | Shares Bid | Bid Amount (₹ Cr) |
|---|---|---|---|
| QIB | 99,75,000 | 1,06,89,028 | 97.27 |
| NII | 19,95,000 | 2,11,61,412 | 192.57 |
| Small NII | 6,65,000 | 1,11,01,488 | 101.02 |
| Big NII | 13,30,000 | 1,00,59,924 | 91.55 |
| RII | 13,30,000 | 6,28,57,920 | 572.01 |
| Total | 1,33,00,000 | 9,47,08,360 | 861.85 |
Company Details
- Anlon Healthcare Ltd.
- 101/102, Silvercoin Complex, Opp.Crystal Mall, Kalawad Road, Rajkot, Gujarat-360005
- +91 281 2562538
- cs@anloncro.com
- http://www.anlon.in/
Registrar Details
- Kfin Technologies Ltd.
- 04067162222, 04079611000
- ahl.ipo@kfintech.com
- https://ipostatus.kfintech.com/
Frequently Asked Questions
See live numbers on GMP, Subscription, and Allotment pages.
Anlon Healthcare IPO News & Updates
Follow the latest updates for Anlon Healthcare IPO, including grey market moves and allotment news.
Anlon Healthcare IPO IPO Pages
Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.
Anlon Healthcare IPO Details
Issue size, price, financials, and company info
Anlon Healthcare IPO GMP
Live grey market premium and listing estimate
Anlon Healthcare IPO Subscription
QIB, NII, Retail, SHNI and BHNI subscription
Anlon Healthcare IPO Allotment
Allotment date, chances, and check by PAN
Anlon Healthcare IPO Review
SWOT, strengths, risks, and IPO review
Anlon Healthcare IPO FAQ
Common questions on dates, GMP, and allotment
Anlon Healthcare IPO Registrar
Registrar website and how to check allotment
Anlon Healthcare IPO Timeline
Open, close, allotment, and listing dates
Anlon Healthcare IPO News
Updates, blogs, and latest IPO news
Sources
We match Anlon Healthcare IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- Kfin Technologies Ltd.Official site to check allotment status for this IPO
Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews IPO dates and key details before they go live.